Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of chemically modified heparin derivates in sickle cell disease

Use of chemically modified heparin derivates in sickle cell disease

US Patent 9480702 · Granted Nov 1, 2016

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Immobilised biological entities2023
Autologous fecal sample for use in the treatment of microbial dysbiosis2021
Low anticoagulant heparins2016
Low anticoagulant heparins2016
Low anticoagulant heparins2016
Non anti-coagulative glycosaminoglycans comprising repeating disaccharide unit a2016
Malaria polypeptides2006
Fractionated heparin for the therapeutic treatment of malaria1995
Fractionated heparin for the therapeutic treatment of malaria1995